Caprock Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,355
| Closed | -$432K | – | 397 |
|
|
2019
Q3 | $432K | Sell |
4,355
-188
| -4% | -$17.9K | 0.08% | 176 |
|
|
2019
Q2 | $420K | Sell |
4,543
-299
| -6% | -$28.4K | 0.08% | 180 |
|
|
2019
Q1 | $457K | Buy |
4,842
+1,445
| +43% | +$126K | 0.09% | 192 |
|
|
2018
Q4 | $218K | Sell |
3,397
-5,585
| -62% | -$412K | 0.05% | 296 |
|
|
2018
Q3 | $804K | Sell |
8,982
-36
| -0.4% | -$3.18K | 0.16% | 115 |
|
|
2018
Q2 | $716K | Buy |
9,018
+444
| +5% | +$36.9K | 0.15% | 129 |
|
|
2018
Q1 | $765K | Buy |
8,574
+2,800
| +48% | +$269K | 0.16% | 119 |
|
|
2017
Q4 | $612K | Sell |
5,774
-270
| -4% | -$30.5K | 0.12% | 172 |
|
|
2017
Q3 | $881K | Buy |
6,044
+446
| +8% | +$60.8K | 0.18% | 113 |
|
|
2017
Q2 | $727K | Sell |
5,598
-2,102
| -27% | -$258K | 0.16% | 130 |
|
|
2017
Q1 | $958K | Buy |
7,700
+130
| +2% | +$15.6K | 0.23% | 83 |
|
|
2016
Q4 | $876K | Sell |
7,570
-516
| -6% | -$57.5K | 0.22% | 94 |
|
|
2016
Q3 | $845K | Buy |
8,086
+197
| +2% | +$21.3K | 0.19% | 118 |
|
|
2016
Q2 | $778K | Buy |
7,889
+388
| +5% | +$40.1K | 0.19% | 126 |
|
|
2016
Q1 | $751K | Buy |
7,501
+734
| +11% | +$75.6K | 0.18% | 122 |
|
|
2015
Q4 | $810K | Buy |
6,767
+4,050
| +149% | +$469K | 0.46% | 39 |
|
|
2015
Q3 | $294K | Sell |
2,717
-9,603
| -78% | -$1.19M | 0.21% | 60 |
|
|
2015
Q2 | $1.43M | Buy |
12,320
+6,086
| +98% | +$696K | 1.31% | 19 |
|
|
2015
Q1 | $719K | Buy |
6,234
+3
| +0% | +$358 | 0.73% | 31 |
|
|
2014
Q4 | $697K | Buy |
+6,231
| New | +$657K | 0.76% | 29 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Caprock Group's CELG Position: Q4 2019 in Review
Caprock Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,355 shares — an estimated $432K sold.
Caprock Group first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $1.43M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Caprock Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Caprock Group sold 4,355 Celgene Corp shares in Q4 2019, an estimated $432K.
- Caprock Group first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
- Caprock Group's Celgene Corp position peaked at $1.43M in Q2 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Caprock Group's 13F filing for Q4 2019, filed 4 Feb 2020.